Ilika Plc Annual Report, AGM and Directorate Change

Ilika Plc

Ilika plc (LON: IKA), a pioneer in solid-state battery technology, confirmed today that the Annual Report and Accounts for the year ended 30th April 2019 and the Notice of Annual General Meeting will be posted to shareholders today. Copies are available on the Company’s website: www.ilika.com/investors

Ilika’s Annual General Meeting will be held at 11.45am on Thursday 26 September 2019 at the offices of Eversheds Sutherland LLP, One Wood Street, London EC2V 7WS.

Ilika announced that with effect from 30 September 2019, Clare Spottiswoode CBE will be retiring from the board of the Company as a Non-Executive Director. Clare was appointed to the Board in May 2010 when the Company completed its IPO and she retires in line with the Company’s best practice governance guidelines.

Jeremy Millard will replace Clare as chair of the audit committee.

Keith Jackson, Chairman of Ilika said:

“The board would like to thank Clare for her service and the contribution she has made to the Company during the past nine years. Clare’s experience has been invaluable in providing wise counsel to the board throughout this exciting period in the Company’s development.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search